Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Zetterstrom, O' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Reichel, W; Dahl, R; Ringdal, N; Zetterstrom, O; Van Den Elshout, FJJ; Laitinen, LA
      Extrafine beclomethasone dipropionate breath-actuated inhaler (400 mu g/day) versus budesonide dry powder inhaler (800 mu g/day) in asthma

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    2. Ferdousi, HA; Munir, AKM; Zetterstrom, O; Dreborg, SKG
      Seasonal differences of peak expiratory flow rate variability and mediators of allergic inflammation in non-atopic adolescents

      PEDIATRIC ALLERGY AND IMMUNOLOGY
    3. Zetterstrom, O; Buhl, R; Mellem, H; Perpina, M; Hedman, J; O'Neill, S; Ekstrom, T
      Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

      EUROPEAN RESPIRATORY JOURNAL
    4. Zetterstrom, O; Lahelma, S; Keski-Karhu, J; Silvasti, M; Ostling-Kulling, E; Ahonen, A
      Salbutamol via Easyhaler (R) is at least as effective as salbutamol via Turbuhaler (R) in the treatment of histamine-induced bronchoconstriction

      RESPIRATORY MEDICINE
    5. Adelroth, E; Rak, S; Haahtela, T; Aasand, G; Rosenhall, L; Zetterstrom, O; Byrne, A; Champain, K; Thirlwell, J; Della Cioppa, G; Sandstrom, T
      Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    6. Fernvik, E; Gronneberg, R; Lundahl, J; Raud, J; Zetterstrom, O; Van Hage-Hamsten, M; Hallden, G
      Characterization of eosinophils and detection of eotaxin in skin chamber fluid after challenge with relevant allergen in patients with mild asthma

      CLINICAL AND EXPERIMENTAL ALLERGY
    7. Lindskog, S; Zetterstrom, O; Kamkar, A; Bergman, E; Forsgardh, A; Blomlof, L
      Skin-prick test for severe marginal periodontitis

      INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
    8. van Hage-Hamsten, M; Kronqvist, M; Zetterstrom, O; Johansson, E; Niederberger, V; Vrtala, S; Gronlund, H; Gronneberg, R; Valenta, R
      Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix oftwo recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    9. DAHLEN B; NIZANKOWSKA E; SZCZEKLIK A; ZETTERSTROM O; BOCHENEK G; KUMLIN M; MASTALERZ L; PINIS G; SWANSON LJ; BOODHOO TI; WRIGHT S; DUBE LM; DAHLEN SE
      BENEFITS FROM ADDING THE 5-LIPOXYGENASE INHIBITOR ZILEUTON TO CONVENTIONAL THERAPY IN ASPIRIN-INTOLERANT ASTHMATICS

      American journal of respiratory and critical care medicine
    10. Ahlbom, A; Backman, A; Bakke, J; Foucard, T; Halken, S; Kjellman, NIM; Malm, L; Skerfving, S; Sundell, J; Zetterstrom, O
      "NORDPET" - Pets indoors - A risk factor for or protection against sensitisation/allergy - A Nordic interdisciplinary review of the scientific literature concerning the relationship between the exposure to pets at home, sensitisation and the development of allergy

      INDOOR AIR-INTERNATIONAL JOURNAL OF INDOOR AIR QUALITY AND CLIMATE
    11. ROQUET A; LAGGING E; IHRE E; VANHAGEHAMSTEN M; HALLDEN G; HARFAST B; ZETTERSTROM O
      NO SIGNS OF ACTIVITY MARKERS IN PERIPHERAL-BLOOD DESPITE INCREASED BRONCHIAL REACTIVITY AFTER REPEATED LOW-DOSE ALLERGEN EXPOSURE

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    12. STJARNE P; RINDER J; HEDENBLOMQUIST E; CARDELL LO; LUNDBERG J; ZETTERSTROM O; ANGGARD A
      CAPSAICIN DESENSITIZATION OF THE NASAL-MUCOSA REDUCES SYMPTOMS UPON ALLERGEN CHALLENGE IN PATIENTS WITH ALLERGIC RHINITIS

      Acta oto-laryngologica
    13. OSTERMAN K; CARLHOLM M; EKELUND J; KIVILOOG J; NIKANDER K; NILHOLM L; SALOMONSSON P; STRAND V; VENGE P; ZETTERSTROM O
      EFFECT OF 1 YEAR DAILY TREATMENT WITH 400 MU-G BUDESONIDE (PUMICORT(R) TURBUHALER(R)) IN NEWLY-DIAGNOSED ASTHMATICS

      The European respiratory journal
    14. ZETTERSTROM O; ANDERSSON C; ERIKSSON L; FREDRIKSSON A; FRISKOPP J; HEDEN G; JANSSON B; LUNDGREN T; NILVEUS R; OLSSON A; RENVERT S; SALONEN L; SJOSTROM L; WINELL A; OSTGREN A; GESTRELIUS S
      CLINICAL SAFETY OF ENAMEL MATRIX DERIVATIVE (EMDOGAIN(R)) IN THE TREATMENT OF PERIODONTAL DEFECTS

      Journal of clinical periodontology
    15. DAHLEN B; KUMLIN M; IHRE E; ZETTERSTROM O; DAHLEN SE
      INHIBITION OF ALLERGEN-INDUCED AIRWAY-OBSTRUCTION AND LEUKOTRIENE GENERATION IN ATOPIC ASTHMATIC SUBJECTS BY THE LEUKOTRIENE BIOSYNTHESIS INHIBITOR BAYX-1005

      Thorax
    16. EVANS DJ; TAYLOR DA; ZETTERSTROM O; CHUNG F; OCONNOR BJ; BARNES PJ
      A COMPARISON OF LOW-DOSE INHALED BUDESONIDE PLUS THEOPHYLLINE AND HIGH-DOSE INHALED BUDESONIDE FOR MODERATE ASTHMA

      The New England journal of medicine
    17. MONTAN PG; VANHAGEHAMSTEN M; ZETTERSTROM O
      SUSTAINED EOSINOPHIL CATIONIC PROTEIN RELEASE INTO TEARS AFTER A SINGLE HIGH-DOSE CONJUNCTIVAL ALLERGEN CHALLENGE

      Clinical and experimental allergy
    18. ROQUET A; HALLDEN G; IHRE E; HED J; ZETTERSTROM O
      EOSINOPHIL ACTIVITY MARKERS IN PERIPHERAL-BLOOD HAVE HIGH PREDICTIVE VALUE FOR BRONCHIAL HYPERREACTIVITY IN PATIENTS WITH SUSPECTED MILD ASTHMA

      Allergy
    19. ROQUET A; IHRE E; VANHAGEHAMSTEN M; HALLDEN G; ZETTERSTROM O
      ALLERGEN-INDUCED INFLAMMATION IN THE NOSE - A COMPARISON OF ACUTE ANDREPEATED LOW-DOSE ALLERGEN EXPOSURE

      Allergy
    20. RAUD J; HALLDEN G; ROQUET A; VANHAGEHAMSTEN M; ALKNER U; HED J; ZETTERSTROM O; DAHLEN SE; HEDQVIST P; GRONNEBERG R
      ANTI-IGE-INDUCED ACCUMULATION OF LEUKOCYTES, MEDIATORS, AND ALBUMIN IN SKIN CHAMBER FLUID FROM HEALTHY AND ATOPIC SUBJECTS

      Journal of allergy and clinical immunology
    21. SKEDINGER M; HALLDEN G; LUNDAHL J; HED J; ZETTERSTROM O
      EOSINOPHIL ACTIVITY REFLECTS CLINICAL STATUS IN PATIENTS WITH ASTHMA BEFORE AND DURING A PREDNISOLONE COURSE

      Annals of allergy, asthma, & immunology
    22. EKSTROM T; OSTERMAN K; ZETTERSTROM O
      LACK OF EFFECT OF LORATADINE ON MODERATE TO SEVERE ASTHMA

      Annals of allergy, asthma, & immunology
    23. LAGERSTRAND L; SKEDINGER M; IHRE E; HALLDEN G; ZETTERSTROM O
      SPIROMETRY AND VENTILATION-PERFUSION INEQUALITY IN PATIENTS WITH MILDALLERGIC-ASTHMA BEFORE AND DURING THE POLLEN SEASON

      Clinical physiology
    24. ROQUET A; RAUD J; HALLDEN G; VANHAGEHAMSTEN M; HED J; HANSSON LO; ZETTERSTROM O; GRONNEBERG R
      EFFECTS OF LORATADINE ON ANTI-IGE-INDUCED INFLAMMATION, HISTAMINE-RELEASE, AND LEUKOCYTE RECRUITMENT IN SKIN OF ATOPICS

      Allergy
    25. OHRN MB; SKOLD CM; VANHAGEHAMSTEN M; SIGURDARDOTTIR O; ZETTERSTROM O; EKLUND A
      SARCOIDOSIS PATIENTS HAVE BRONCHIAL HYPERREACTIVITY AND SIGNS OF MAST-CELL ACTIVATION IN THEIR BRONCHOALVEOLAR LAVAGE

      Respiration
    26. DAHLEN B; ZETTERSTROM O; BJORCK T; DAHLEN SE
      THE LEUKOTRIENE-ANTAGONIST ICI-204,219 INHIBITS THE EARLY AIRWAY REACTION TO CUMULATIVE BRONCHIAL CHALLENGE WITH ALLERGEN IN ATOPIC ASTHMATICS

      The European respiratory journal
    27. PERSSON MG; ZETTERSTROM O; AGRENIUS V; IHRE E; GUSTAFSSON LE
      SINGLE-BREATH NITRIC-OXIDE MEASUREMENTS IN ASTHMATIC-PATIENTS AND SMOKERS

      Lancet
    28. MONTAN P; ZETTERSTROM O; ELIASSON E; STROMQUIST LH
      TOPICAL SODIUM CROMOGLYCATE (OPTICROM(R)) RELIEVES ONGOING SYMPTOMS OF ALLERGIC CONJUNCTIVITIS WITHIN 2 MINUTES

      Allergy
    29. AXELSSON IGK; IHRE E; ZETTERSTROM O
      ANAPHYLACTIC REACTIONS TO SUNFLOWER SEED

      Allergy
    30. DAHLEN B; BOREUS LO; ANDERSON P; ANDERSSON R; ZETTERSTROM O
      PLASMA ACETYLSALICYLIC-ACID AND SALICYLIC-ACID LEVELS DURING ASPIRIN PROVOCATION IN ASPIRIN-SENSITIVE SUBJECTS

      Allergy
    31. ROQUET A; RAUD J; HALLDEN G; HED J; VANHAGEHAMSTEN M; ZETTERSTROM O
      EFFECT OF LORATADINE ON ANTI-IGE MEDIATED SKIN REACTIONS AND MEDIATORRELEASE AND INFLAMMATORY EVENTS IN SKIN CHAMBERS IN ATOPICS

      Journal of allergy and clinical immunology
    32. IHRE E; HALLDEN G; HED J; ZETTERSTROM O
      CHANGE IN EOSINOPHIL ACTIVITY AND BHR AFTER REPEATED LOW-DOSE ALLERGEN EXPOSURE

      Journal of allergy and clinical immunology
    33. GRONNEBERG R; HALLDEN G; VANHAGEHAMSTEN M; DAHLEN SE; ZETTERSTROM O; RAUD J
      EFFECTS OF SALMETEROL AND TERBUTALINE ON IGE MEDIATED SKIN REACTIONS AND MEDIATOR RELEASE AND INFLAMMATORY EVENTS IN SKIN CHAMBERS IN NORMAL AND ATOPIC SUBJECTS

      Journal of allergy and clinical immunology
    34. STALENHEIM G; WEGENER T; GRETTVE L; LUNDBACK B; MELANDER B; OSTERMAN K; PIITULAINEN E; ZETTERSTROM O
      EFFICACY AND TOLERANCE OF A 12-WEEK TREATMENT WITH INHALED FORMOTEROLIN PATIENTS WITH REVERSIBLE OBSTRUCTIVE LUNG-DISEASE

      Respiration
    35. IHRE E; ZETTERSTROM O
      INCREASE IN NONSPECIFIC BRONCHIAL RESPONSIVENESS AFTER REPEATED INHALATION OF LOW-DOSES OF ALLERGEN

      Clinical and experimental allergy
    36. DAHLEN B; KUMLIN M; MARGOLSKEE DJ; LARSSON C; BLOMQVIST H; WILLIAMS VC; ZETTERSTROM O; DAHLEN SE
      THE LEUKOTRIENE-RECEPTOR ANTAGONIST MK-0679 BLOCKS AIRWAY-OBSTRUCTIONINDUCED BY INHALED LYSINE-ASPIRIN IN ASPIRIN-SENSITIVE ASTHMATICS

      The European respiratory journal
    37. DAHLEN B; MARGOLSKEE DJ; ZETTERSTROM O; DAHLEN SE
      EFFECT OF THE LEUKOTRIENE RECEPTOR ANTAGONIST MK-0679 ON BASE-LINE PULMONARY-FUNCTION IN ASPIRIN-SENSITIVE ASTHMATIC SUBJECTS

      Thorax
    38. KUMLIN M; FRANZEN L; STENSVAD F; DAHLEN B; IHRE E; LARSSON C; BLOMQVIST H; ZETTERSTROM O; DAHLEN SE
      IMPROVED STRATEGY FOR ANALYSIS OF LEUKOTRIENE E4 IN THE URINE

      The American review of respiratory disease
    39. DAHLEN SE; DAHLEN B; IHRE E; KUMLIN M; FRANZEN L; STENSVAD F; LARSSON C; BLOMQVIST H; BJORCK T; ZETTERSTROM O
      THE LEUKOTRIENE BIOSYNTHESIS INHIBITOR BAY X1005 IS A POTENT INHIBITOR OF ALLERGEN-INDUCED AIRWAY-OBSTRUCTION AND LEUKOTRIENE FORMATION IN MAN

      The American review of respiratory disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/10/20 alle ore 23:57:32